| Bloomberg Novartis AG agreed to buy Glaxo’s cancer-drug business for as much as $16 billion while selling most of the company’s vaccines division to Glaxo for $7.1 billion and its animal-health unit to Eli Lilly & Co. for $5.4 billion. Close. Novartis AG agreed to buy … Glaxo, Novartis Keep Deal-Making on TargetWall Street Journal Novartis to buy GlaxoSmithKline cancer unit for up to $16 billionLos Angeles Times Novartis Buys Glaxo Cancer Drugs Amid $28.5B of Deals in CEO Jimenez’s …Businessweek Fox Business –ABC News –Economic Times all 360 news articles |
Source: Business News From Google News